Skip to main content
logo
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.9998
+0.0014 (0.14%)
Apr 13, 2026, 12:35 PM EDT - Market open

Sunshine Biopharma Revenue

In the year 2025, Sunshine Biopharma had annual revenue of $36.31M with 4.11% growth. Sunshine Biopharma had revenue of $8.58M in the quarter ending December 31, 2025, a decrease of -10.61%.

Revenue (ttm)
$36.31M
Revenue Growth
+4.11%
P/S Ratio
0.13
Revenue / Employee
$698,190
Employees
52
Market Cap
4.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.31M1.43M4.11%
Dec 31, 202434.87M10.78M44.75%
Dec 31, 202324.09M19.75M454.42%
Dec 31, 20224.35M4.12M1,802.41%
Dec 31, 2021228.43K157.02K219.88%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biofrontera41.71M
IM Cannabis39.92M
cbdMD19.09M
Universe Pharmaceuticals INC17.86M
Sonoma Pharmaceuticals17.72M
RedHill Biopharma9.55M
InMed Pharmaceuticals4.51M
China SXT Pharmaceuticals1.54M
Revenue Rankings

SBFM News

More News